Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Betty S. Apica"'
Autor:
Joan Nankya-Mutyoba, Betty S. Apica, Grace Otekat, Dorothy B. Kyeyune, Lourita Nakyagaba, Joletta Nabunje, Mary Nakafeero, Emmanuel Seremba, Ponsiano Ocama
Publikováno v:
Journal of Virus Eradication, Vol 7, Iss 2, Pp 100041- (2021)
Background: The drive to eliminate viral hepatitis by 2030 is underway. However, locally generated data on active infection is required to focus such efforts. We performed a regionally-inclusive survey to determine prevalence of active HCV, genotypes
Externí odkaz:
https://doaj.org/article/9fe1b9a7713e4693b30e1a4be94dea5c
Autor:
Jackie T. Zirabamuzale, Christopher K. Opio, Freddie Bwanga, Emmanuel Seremba, Betty S. Apica, Robert Colebunders, Ponsiano Ocama
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss 1, Pp 19-21 (2016)
Background: The prevalence of hepatitis B virus (HBV) infection in Uganda is 10%. Hepatitis B virus genotypes impact on treatment response, rate of spontaneous recovery and progression of chronic HBV infection and hepatocellular carcinoma. There is l
Externí odkaz:
https://doaj.org/article/a0c7c3e271594e6b975eeaf81c2c738a
Autor:
Grace Otekat, Betty S. Apica, Dorothy Kyeyune, Emmanuel Seremba, Mary Nakafeero, Lourita Nakyagaba, Ponsiano Ocama, Joan Nankya-Mutyoba, Joletta Nabunje
Publikováno v:
Journal of Virus Eradication
Journal of Virus Eradication, Vol 7, Iss 2, Pp 100041-(2021)
Journal of Virus Eradication, Vol 7, Iss 2, Pp 100041-(2021)
Background The drive to eliminate viral hepatitis by 2030 is underway. However, locally generated data on active infection is required to focus such efforts. We performed a regionally-inclusive survey to determine prevalence of active HCV, genotypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b8b9cf160ade61b4a63734b18f8e0b2
http://europepmc.org/articles/PMC8219885
http://europepmc.org/articles/PMC8219885
Autor:
Mark W. Sonderup, Olufunmilayo A. Lesi, C Wendy Spearman, Chris Kassianides, Lina Cunha, Christian Tzeuton, John Rwegasha, Papa Saliou Mbaye, Emmanuel Musabeyezu, Betty S. Apica, Geoffrey Dusheiko, Mary Afihene, Reidwaan Ally, Marie-Jeanne Lohouès-Kouacou, Phillip Lam, Yaw Asante Awuku, Neliswa Gogela, Olesegun Ojo, Betty Musau, Abate B. Shewaye, Barbara Scholz
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:910-919
In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030. Africa, and more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of viral hepatitis, especially chronic hepatitis B and hepatitis C v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f110859266a57f77bdfc5c227ffb5d5c
https://doi.org/10.1016/s2468-1253(17)30249-2
https://doi.org/10.1016/s2468-1253(17)30249-2
Autor:
Philip Lam, Reidwaan Ally, Chris Kassianides, John Rwegasha, Olufunmilayo A. Lesi, Emmanuel Musabeyezu, Christian Tzeuton, Mark W. Sonderup, Michael C. Kew, Neliswa Gogela, Geoffrey Dusheiko, Yaw Asante Awuku, Lina Cunha, Betty Musau, Abate B. Shewaye, Barbara Scholz, O S Ojo, Papa Saliou Mbaye, C Wendy Spearman, Marie Jeanne Lohouès-Kouacou, Betty S. Apica, Mary Afihene
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:900-909
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in mortality due to hepatitis B and C by 2030. Hepatitis B virus (HBV) is en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aac53524c08f578daedc126d7246b91
https://doi.org/10.1016/s2468-1253(17)30295-9
https://doi.org/10.1016/s2468-1253(17)30295-9
Publikováno v:
Journal of Medical Virology. 88:674-680
Occult hepatitis B infection (OBI), the presence of low hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels in patients without detectable hepatitis B surface antigen (HBsAg), has significant implications for understanding the natural history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f86176dd7720e40931e67baeae1a780f
https://doi.org/10.1002/jmv.24372
https://doi.org/10.1002/jmv.24372
Autor:
Ponsiano Ocama, Christopher Kenneth Opio, Betty S. Apica, Freddie Bwanga, Emmanuel Seremba, Jackie T. Zirabamuzale, Robert Colebunders
Publikováno v:
JOURNAL OF VIRUS ERADICATION
Journal of Virus Eradication
Journal of Virus Eradication, Vol 2, Iss 1, Pp 19-21 (2016)
Journal of Virus Eradication
Journal of Virus Eradication, Vol 2, Iss 1, Pp 19-21 (2016)
Background The prevalence of hepatitis B virus (HBV) infection in Uganda is 10%. Hepatitis B virus genotypes impact on treatment response, rate of spontaneous recovery and progression of chronic HBV infection and hepatocellular carcinoma. There is li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fb856050bca93e81d40ad43600bae1
https://doi.org/10.1016/s2055-6640(20)30693-2
https://doi.org/10.1016/s2055-6640(20)30693-2
Publikováno v:
Journal of medical virology. 88(4)
Occult hepatitis B infection (OBI), the presence of low hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels in patients without detectable hepatitis B surface antigen (HBsAg), has significant implications for understanding the natural history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7fb9d2d8c395640057ef455c10c0465
https://pubmed.ncbi.nlm.nih.gov/26334654
https://pubmed.ncbi.nlm.nih.gov/26334654
Publikováno v:
African Health Sciences; Vol 15, No 2 (2015); 328-333
Background : Hepatitis B virus (HBV) and HIV are endemic in Uganda. Co-infection is common and leads to rapid progression of liver disease. Burden of co-infection is unknown yet most patients are on lamivudine-only ART where resistance is frequent. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c859094a7989e90355a8357f3bce0af
https://www.ajol.info/index.php/ahs/article/view/117503
https://www.ajol.info/index.php/ahs/article/view/117503
Autor:
Paul Ajal, Emmanuel Odongo Aginya, Kenneth Opio, Ponsiano Ocama, Emmanuel Seremba, Betty S. Apica
Publikováno v:
African Health Sciences. 17:301
Introduction: Both Human Immunodeficiency Virus (HIV) and S.mansoni infections are common in Uganda and can cause liver disease. No study has determined co-infection significance in Uganda. We carried out a study on the burden, pattern and factors th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3633595dc0d4539df19c385f8741e5d5
https://doi.org/10.4314/ahs.v17i2.2
https://doi.org/10.4314/ahs.v17i2.2